DarioHealth Corp. Common StockDRIO
Recorded

DarioHealth Corp. Common Stock 2026 Q2 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ2 2026Duration40 minParticipants7

Transcript

Preview the first five paragraphs, organized by speaker.

Operator

Good morning, ladies and gentlemen, and welcome to the DarioHealth Second Quarter 2026 Results Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Tuesday, August 11, 2026. I would now like to turn the conference over to Zoe Harrison, VP Accounting and Corporate Development at DarioHealth.

Zoe HarrisonVP of Accounting and Corporate Development

Zoe, please go ahead. Thank you, operator, and good morning everyone.

Zoe HarrisonVP of Accounting and Corporate Development

Thank you for joining us today for a discussion of DarioHealth's second quarter of 2026 financial results. Leading the call today will be Erez Raphael, Chief Executive Officer of DarioHealth, who will be joined by Chen Franco-Yehuda, our Chief Financial Officer, and our Chief Operating Officer, Lara Dodo. Steven Nelson, the company's President and Chief Commercial Officer, is on medical leave. An audio recording and webcast replay for today's call will also be available online, as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast, this call is being held on Tuesday, August 11, 2026. This morning, we issued a press release announcing our financial results for the second quarter of 2026. A copy of the release can be found on the investor relations page of DarioHealth's website.

Zoe HarrisonVP of Accounting and Corporate Development

I would like to remind you that on this call, management will make forward-looking statements within the meaning of the federal securities law.

Zoe HarrisonVP of Accounting and Corporate Development

For example, the company is using forward-looking statements when it discusses expected revenue growth and contribution from signed accounts, its path to profitability and positive cash flow, the continued reduction in operating expenses and losses, its expansion of channel partnerships and distribution, expected revenue and scaling from partner-led opportunities, expected onboarding, implementation, and enrollment of large enterprise accounts, expected conversion of contracted annual recurring revenue into recognized revenue, expected expansion into care delivery, claims-based and outcomes-based models, expected benefits from care delivery participants, expected growth in recurring revenue and operating leverage, expected advantages and future impacts of DarioIQ and proprietary data assets, expected improvements in member engagement, retention, and outcomes, the anticipated benefits of artificial intelligence across the company's commercial operations and internal operations, the anticipated expansion of existing customer relationships into additional chronic conditions, the expected timing and contribution of new product offerings, the company's ability to increase revenue per customer through its multi-condition strategy, the expected benefits of provider-backed clinical care, and beliefs regarding competitive positioning and market opportunity.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Explore more earnings calls.

View earnings calendar